Cargando…
Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile
Hepatocellular carcinoma is often treated with a combination of doxorubicin and embolization, exposing it to high concentrations and hypoxia. Separation of the possible synergistic effect of this combination in vivo is difficult. Here, treatment with doxorubicin, under hypoxia or normoxia in differe...
Autores principales: | Dubbelboer, Ilse R., Pavlovic, Natasa, Heindryckx, Femke, Sjögren, Erik, Lennernäs, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678640/ https://www.ncbi.nlm.nih.gov/pubmed/31330834 http://dx.doi.org/10.3390/cancers11071024 |
Ejemplares similares
-
In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma
por: Kullenberg, Fredrik, et al.
Publicado: (2021) -
Exploring the Role of Endoplasmic Reticulum Stress in Hepatocellular Carcinoma through mining of the Human Protein Atlas
por: Pavlović, Nataša, et al.
Publicado: (2021) -
Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma
por: Ebeling Barbier, Charlotte, et al.
Publicado: (2021) -
Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
por: Khaled, Jaafar, et al.
Publicado: (2022) -
Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death
por: Balgoma, David, et al.
Publicado: (2021)